Breaking
RAPS Euro Convergence: Top Regulatory Insights - Day 1European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1
🇺🇸 FDA

Cellular Rejuvenation

Page 1 • 1 item

Uncover global pharma market insights on cellular rejuvenation therapies. Stay ahead in drug development, investment, and regulatory strategy.

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion
NewsAnti-aging/Longevity/Cellular RejuvenationApr 23, 2026

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion

Avaí Bio becomes first company to receive FDA clearance for cellular rejuvenation trial, marking milestone in $120 billion anti-aging market by 2030.

James Chen, PharmD